Spectral Med Stock Analysis

Spectral Pink Sheet Analysis Notes

About 20.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.03. Spectral Med last dividend was issued on the 19th of December 2011. Spectral Medical Inc., together with its subsidiaries, focuses on the development and commercialization of products for the treatment of septic shock and renal disease in North America. Spectral Medical Inc. was incorporated in 1991 and is headquartered in Toronto, Canada. SPECTRAL MEDICAL operates under Diagnostics Research classification in the United States and is traded on OTC Exchange. It employs 31 people.The quote for Spectral Med is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To learn more about Spectral Med call Christopher Seto at 416-626-3233 or check out https://www.spectraldx.com.

Spectral Med Investment Alerts

Spectral Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 66.02 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Spectral Med's market, we take the total number of its shares issued and multiply it by Spectral Med's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Technical Drivers

As of the 20th of January, Spectral Med has the Risk Adjusted Performance of (0.02), coefficient of variation of (3,442), and Variance of 21.4. Spectral Med technical analysis provides you with a way to harness past market data to determine a pattern that measures the direction of the company's future prices. Please validate Spectral Med mean deviation, treynor ratio, as well as the relationship between the Treynor Ratio and kurtosis to decide if Spectral Med is priced more or less accurately, providing market reflects its prevalent price of 0.35 per share. As Spectral Med appears to be a penny stock we also recommend to double-check its jensen alpha numbers.

Spectral Med Price Movement Analysis

Spectral Med Outstanding Bonds

Spectral Med Predictive Daily Indicators

Spectral Med Forecast Models

Spectral Med's time-series forecasting models are one of many Spectral Med's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Spectral Med's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Spectral Med prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Spectral shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Spectral Med. By using and applying Spectral Pink Sheet analysis, traders can create a robust methodology for identifying Spectral entry and exit points for their positions.

When running Spectral Med's price analysis, check to measure Spectral Med's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Spectral Med is operating at the current time. Most of Spectral Med's value examination focuses on studying past and present price action to predict the probability of Spectral Med's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Spectral Med's price. Additionally, you may evaluate how the addition of Spectral Med to your portfolios can decrease your overall portfolio volatility.